BOSTON MEDICAL CENTER CORPORATION
Federal contractor profile
Total Awards
4
Total Obligated
$453,078.66
Agencies Served
2
Expiring Contracts
3
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 3 | $325,937.02 |
| Department of Veterans Affairs | 1 | $127,141.64 |
Top NAICS Codes
Expiring Contracts (3)
36C24126C0007289 days remaining
OPHTHALMOLOGY PHYSICIAN SERVICES
Department of Veterans Affairs|Expires Jan 31, 2027
$127,141.64
75N94025F0000113 days remaining
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services|Expires Apr 30, 2026
$99,921.01
75N94025F0000113 days remaining
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services|Expires Apr 30, 2026
$99,921.01
All Awards
FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENTNO SET ASIDE USED.
OPHTHALMOLOGY PHYSICIAN SERVICES
Department of Veterans Affairs36C24126C0007$127,141.64
COST NO FEE
75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183
Department of Health and Human Services75N94023F00001$126,095
COST NO FEE
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services75N94025F00001$99,921.01
COST NO FEE
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Department of Health and Human Services75N94025F00001$99,921.01